Aspirin for diabetes: are we adhering to ADA guidelines?
Aakash
Sabitha
P
P
D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D048909:Diabetes Complications; D003920:Diabetes Mellitus; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D019983:Guideline Adherence; D006306:Health Surveys; D006801:Humans; D017410:Practice Guidelines as Topic; D014481:United States
D005343:Fibrinolytic Agents; D001241:Aspirin